3 completed, 1 recruiting, 1 terminated, 1 unknown. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 3, Recruiting 1, Terminated 1, Unknown 1 |
Follow Orchiectomy: new trials by email Literature Review of Orchiectomy trials Research Report on Orchiectomy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer Abiraterone, Bicalutamide, Degarelix - Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma | Phase 3 | Recruiting | SWOG Cancer Research Network | 1273 | 2018-09-24 | 2026-10-08 |
| Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer antiandrogen therapy, docetaxel, goserelin acetate - Prostate Cancer | Phase 3 | Completed | UNICANCER | 385 | 2004-10-18 | 2021-02-21 |
| Androgen Deprivation Therapy in Treating Patients With Prostate Cancer antiandrogen therapy, releasing hormone agonist therapy, orchiectomy - Prostate Cancer | Phase 3 | Unknown | Peter MacCallum Cancer Centre, Australia | 2000 | 2004-10-01 | 2013-08-07 |
| Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer bicalutamide, goserelin acetate, orchiectomy - Prostate Cancer | Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 110 | 2001-01-01 | 2012-09-24 |
| Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer flutamide, goserelin acetate, leuprolide acetate - Prostate Cancer | Phase 3 | Completed | Eastern Cooperative Oncology Group | 1996-10-01 | 2010-11-09 | |
| Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer bicalutamide, buserelin, flutamide - Prostate Cancer | Phase 3 | Completed | NCIC Clinical Trials Group | 361 | 1995-02-08 | 2020-04-03 |
Eastern Cooperative Oncology Group (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · NCIC Clinical Trials Group (1) · Peter MacCallum Cancer Centre, Australia (1) · SWOG Cancer Research Network (1) · UNICANCER (1)
United States (2) · Australia (1) · Canada (1) · Chile (1) · Colombia (1) · France (1) · Germany (1) · Mexico (1) · New Zealand (1) · Switzerland (1)
A. O. Sartor, MD (1) · Brian Chapin (1) · George Wilding, MD (1) · Gerald H.J. Mickisch, MD (1) · Gillian M. Duchesne, MD, FRCR (1) · Gwenaelle Gravis, MD (1) · Malcolm D. Mason, MD (1) · Nancy A. Dawson, MD (1) · Padraig R. Warde, MB, MRCPI, FRCPC (1) · Patricia Lillis-Hearne, MD (1) · Richard R. Whittington, MD (1) · Srinivasan Vijayakumar, MD (1)
PMID 22056152, PMID 22747660, PMID 23306100, PMID 24210084, PMID 25592642, PMID 25691677, PMID 26014295, PMID 27155740, PMID 28760403
U10CA180888 (1)